Liu Yi, Wang Wei-Mao, Zou Li-Yi, Li Li, Feng Lu, Pan Ming-Zhu, Lv Min-Yi, Cao Ying, Wang Hua, Kung Hsiang-Fu, Pang Jian-Xin, Fu Wei-Ming, Zhang Jin-Fang
Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang, Guangdong, P. R. China.
School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Proteomics. 2017 Jun;17(12). doi: 10.1002/pmic.201600350.
Hpn is a small histidine-rich cytoplasmic protein from Helicobacter pylori and has been recognized as a high-risk factor for several cancers including gastric cancer, colorectal cancer, and MALT lymphoma. However, the relationship between Hpn and cancers remains elusive. In this study, we discovered that Hpn protein effectively suppressed cell growth and induced apoptosis in hepatocellular carcinoma (HCC). A two-dimensional gel electrophoresis and mass spectrometry-based comparative proteomics was performed to find the molecular targets of Hpn in HCC cells. It was identified that twelve proteins were differentially expressed, with USP5 being one of the most significantly downregulated protein. The P14 -P53 signaling was activated by USP5 knockdown in HCC cells. Furthermore, USP5 overexpression significantly rescued the suppressive effect of Hpn on the viability of HCC cells. In conclusion, our study suggests that Hpn plays apoptosis-inducing roles through suppressing USP5 expression and activating the P14 -P53 signaling. Therefore, Hpn may be a potential candidate for developing novel anti-HCC drugs.
幽门螺杆菌富含组氨酸的小细胞质蛋白(Hpn)已被认为是包括胃癌、结直肠癌和黏膜相关淋巴组织淋巴瘤在内的多种癌症的高危因素。然而,Hpn与癌症之间的关系仍不清楚。在本研究中,我们发现Hpn蛋白可有效抑制肝癌(HCC)细胞的生长并诱导其凋亡。我们进行了基于二维凝胶电泳和质谱的比较蛋白质组学研究,以寻找Hpn在肝癌细胞中的分子靶点。结果鉴定出12种差异表达的蛋白质,泛素特异性蛋白酶5(USP5)是下调最显著的蛋白质之一。在肝癌细胞中,USP5基因敲低激活了P14-P53信号通路。此外,USP5过表达显著挽救了Hpn对肝癌细胞活力的抑制作用。总之,我们的研究表明,Hpn通过抑制USP5表达并激活P14-P53信号通路发挥诱导凋亡的作用。因此,Hpn可能是开发新型抗肝癌药物的潜在候选物。